1. Home
  2. SYRE vs CSTM Comparison

SYRE vs CSTM Comparison

Compare SYRE & CSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$43.49

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Constellium SE (France)

CSTM

Constellium SE (France)

HOLD

Current Price

$24.93

Market Cap

3.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYRE
CSTM
Founded
2013
2010
Country
United States
France
Employees
N/A
11500
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.1B
IPO Year
2015
2012

Fundamental Metrics

Financial Performance
Metric
SYRE
CSTM
Price
$43.49
$24.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
4
Target Price
$55.57
$29.00
AVG Volume (30 Days)
655.8K
2.3M
Earning Date
05-19-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
405.26
EPS
N/A
1.92
Revenue
N/A
$8,449,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.46
P/E Ratio
N/A
$13.50
Revenue Growth
N/A
15.19
52 Week Low
$10.91
$7.33
52 Week High
$45.76
$27.25

Technical Indicators

Market Signals
Indicator
SYRE
CSTM
Relative Strength Index (RSI) 71.28 54.34
Support Level $14.62 $22.14
Resistance Level N/A $27.25
Average True Range (ATR) 2.29 1.18
MACD 0.74 -0.09
Stochastic Oscillator 79.60 47.67

Price Performance

Historical Comparison
SYRE
CSTM

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About CSTM Constellium SE (France)

Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: the Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium sheet products in European and North American facilities; the Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities; the Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.

Share on Social Networks: